Corrigendum: PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single Institution
oleh: Sonia Pernas, Anna Petit, Fina Climent, Laia Paré, J. Perez-Martin, Luz Ventura, Milana Bergamino, Patricia Galván, Catalina Falo, Idoia Morilla, Adela Fernandez-Ortega, Agostina Stradella, Montse Rey, Amparo Garcia-Tejedor, Miguel Gil-Gil, Aleix Prat
| Format: | Article |
|---|---|
| Diterbitkan: | Frontiers Media S.A. 2019-09-01 |
Deskripsi
Subjek
breast cancer; HER2; pathological complete response; gene expression; molecular intrinsic subtype; residual disease